Thyroid cancer : a comprehensive guide to clinical management
著者
書誌事項
Thyroid cancer : a comprehensive guide to clinical management
Humana Press, c2006
2nd ed
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
HTTP:URL=http://www.loc.gov/catdir/toc/ecip061/2005029167.html Information=Table of contents only
HTTP:URL=http://www.loc.gov/catdir/enhancements/fy0825/2005029167-d.html Information=Publisher description
内容説明・目次
内容説明
are new to this edition. The authors provide not only the The second edition of Thyroid Cancer: A Comp- most current review of their respective areas, but also their hensive Guide to Clinical Management marks the pub- own recommendations and approach. The reader is fo- cation of a markedly updated and expanded volume that warned that in many cases these approaches, albeit rooted covers all aspects of the etiology, pathogenesis, diag- sis, initial treatment, and long-term management of all in available data, may be empiric rather than based varieties of thyroid cancer. Like the first edition, it will upon clear-cut results of well-controlled clinical t- als. Nevertheless, controversial issues are examined serve as a valuable reference source for pathologists, and evidence-based recommendations are presented endocrine surgeons, endocrinologists, nuclear medicine when available. physicians, and oncologists. However, the biggest There are updated chapters on our current state change is that the second edition is significantly enlarged and expanded to encompass important and extensive of knowledge of the molecular changes in thyroid treatments of more topics related to nuclear medicine. cancer, molecular markers, and how targeted the- pies are being developed.
New therapeutic trials of Nuclear medicine physicians and procedures play a key redifferentiation agents to restore the sodium iodide role in the management of thyroid cancer patients and in symporter when lacking and more traditional che- retrospect, a comprehensive discussion of topics related therapies are discussed, with referral sources listed for to that field was somewhat lacking in the first edition.
目次
Part I. General Considerations I: Thyroid Cancer Anatomy and Physiology of the Thyroid Gland: Clinical Correlates to Thyroid Cancer Nikolaos Stathatos Epidemiology of Thyroid Cancer James J. Figge Molecular Pathogenesis of Thyroid Cancer James J. Figge, Nikolai A. Kartel, Dima Yarmolinsky, and Gennady Ermak Molecular Aspects of Thyroid Cancer in Children Gary L. Francis Oncogenes in Thyroid Cancer Katherine B. Weber and Michael T. McDermott Apoptosis in Thyroid Cancer Su He Wang and James R. Baker, Jr. Radiation-Induced Thyroid Cancer James J. Figge, Timothy Jennings, Gregory Gerasimov, Nikolai A. Kartel, Dima Yarmolinsky, and Gennady Ermak Classification of Thyroid Malignancies Yolanda C. Oertel Staging of Thyroid Cancer Leonard Wartofsky Thyroid Cancer in Children and Adolescents Merrily Poth Recombinant Human Thyrotropin Matthew D. Ringel and Stephen J. Burgun Part II. General Considerations II: Nuclear Medicine History of the Role of Nuclear Medicine in the Thyroid Gland and its Diseases: A Personal Perspective Henry N. Wagner, Jr. Prophylaxis against Radiation Exposure from Radioiodine Jacob Robbins and Arthur B. Schneider Radioiodine Whole Body Imaging Frank B. Atkins and Douglas Van Nostrand Primer and Atlas for the Interpretation of Radioiodine Whole-Body Scintigraphy Douglas Van Nostrand, Reetha Bakthula, and Frank B. Atkins False-Positive Radioiodine Scans in Thyroid Cancer Brahm Shapiro, Vittoria Rufini, Ayman Jarwan, Onelio Geatti, Kimberlee J. Kearfott, Lorraine M. Fig, Ian D. Kirkwood, John E. Freitas, and Milton D. Gross Part III. The Thyroid Nodule The Thyroid Nodule: Evaluation, Risk of Malignancy, and Management Leonard Wartofsky Fine Needle Aspiration: Technique Yolanda C. Oertel Thyroid Nodules: Cellular and Biochemical Markers for Malignancy Kathleen A. Prendergast Radionuclide Imaging of Thyroid Nodules Douglas Van Nostrand Ultrasonic Imaging of the Neck in Patients with Thyroid Cancer Manfred Blum Thyroid Nodules and Cancer Risk: Surgical Management Orlo H. Clark Part IV. Well-Differentiated Thyroid Cancer: Papillary Carcinoma A. Presentation Papillary Cancer: Clinical Aspects Leonard Wartofsky Surgical Approach to Papillary Cancer Orlo H. Clark Papillary Carcinoma: Cytology and Pathology Yolanda C. Oertel and James E. Oertel Part IV. Well-Differentiated Thyroid Cancer: B. Initial Management Prescribed Activity for Radioiodine Ablation Douglas Van Nostrand Thyroid Remnant Radioiodine Ablation with Recombinant Human Thyrotropin R. Michael Tuttle and Richard J. Robbins Part IV. Well-Differentiated Thyroid Cancer: C. Surveillance Follow-Up Strategy in Papillary Thyroid Cancer Henry B. Burch Levothyroxine Therapy and Thyrotropin Suppression Leonard Wartofsky Thyroglobulin and Thyroglobulin Antibodies: Measurement and Interferences D. Robert Dufour Diagnosis of Recurrent Thyroid Cancer in Patients with Positive Antithyroglobulin Antibodies Matthew D. Ringel Surveillance Radioiodine Whole-Body Scans Douglas Van Nostrand Radionuclide Imaging and Treatment of Thyroid Cancer in Children Gary L. Francis Positron Emission Tomography in Well-Differentiated Thyroid Cancer I. Ross McDougall Alternative Thyroid Imaging Anca M. Avram, Karen C. Rosenspire, Stewart C. Davidson, John E. Freitas, and Milton D. Gross The 'Stunning' Controversy. A. Stunning: Untoward Effect of 13
「Nielsen BookData」 より